Consolidated Balance Sheets - USD ($)	Dec. 31, 2024	Dec. 31, 2023
Assets
Loans receivable	$ 65,974,265	$ 73,048,403
Interest and other fees receivable on loans	1,521,033	1,395,905
Cash	178,012	104,222
Cash - restricted	23,750	1,587,773
Other assets	62,080	63,636
Right-of-use asset - operating lease, net	154,039	207,364
Deferred financing costs, net	16,171	27,583
Total assets	67,929,350	76,434,886
Liabilities:
Line of credit	16,427,874	25,152,338
Senior secured notes (net of deferred financing costs of $96,985 and $172,069, respectively)	5,903,015	5,827,931
Deferred origination fees	568,534	719,019
Accounts payable and accrued expenses	232,236	295,292
Operating lease liability	167,119	220,527
Loan holdback	50,000
Dividends payable	1,315,445	1,287,073
Total liabilities	24,664,223	33,502,180
Commitments and contingencies
Stockholders’ equity:
Preferred shares - $.01 par value; 5,000,000 shares authorized; none issued
Common shares - $.001 par value; 25,000,000 shares authorized; 11,757,058 issued; 11,438,651 and 11,440,651 outstanding, respectively	11,757	11,757
Additional paid-in capital	45,561,941	45,548,876
Less: Treasury stock, at cost – 318,407 and 316,407 shares	(1,070,406)	(1,060,606)
Accumulated deficit	(1,238,165)	(1,567,321)
Total stockholders’ equity	43,265,127	42,932,706
Total liabilities and stockholders’ equity	$ 67,929,350	$ 76,434,886